Hyorakel Invest ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.5% 1.6% 1.5% 1.4% 1.1%  
Credit score (0-100)  76 74 76 77 85  
Credit rating  A A A A A  
Credit limit (kDKK)  29.9 27.7 52.0 150.2 928.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -5.0 -122 -114 -83.8 -125  
EBITDA  -5.0 -122 -114 -83.8 -125  
EBIT  -5.0 -122 -114 -83.8 -125  
Pre-tax profit (PTP)  3,730.4 3,669.6 1,206.0 5,057.7 5,022.0  
Net earnings  3,520.0 3,478.2 1,556.8 4,738.8 4,710.0  
Pre-tax profit without non-rec. items  3,730 3,670 1,206 5,058 5,022  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  7,738 11,217 12,523 16,512 20,872  
Interest-bearing liabilities  1,080 843 837 324 88.3  
Balance sheet total (assets)  9,107 12,327 13,401 17,760 22,201  

Net Debt  -4,334 -7,751 -8,758 -11,653 -16,236  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -5.0 -122 -114 -83.8 -125  
Gross profit growth  0.0% -2,341.3% 6.9% 26.2% -49.6%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,107 12,327 13,401 17,760 22,201  
Balance sheet change%  58.4% 35.4% 8.7% 32.5% 25.0%  
Added value  -5.0 -122.1 -113.7 -83.8 -125.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  50.7% 34.8% 22.0% 34.8% 26.1%  
ROI %  52.3% 35.7% 22.3% 35.9% 27.6%  
ROE %  54.3% 36.7% 13.1% 32.6% 25.2%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  85.0% 91.0% 93.4% 93.0% 94.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  86,671.8% 6,349.9% 7,705.7% 13,900.0% 12,942.7%  
Gearing %  14.0% 7.5% 6.7% 2.0% 0.4%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 6.4% 193.7% 62.9% 95.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  4.6 8.5 11.9 10.5 13.1  
Current Ratio  4.6 8.5 11.9 10.5 13.1  
Cash and cash equivalent  5,413.6 8,594.2 9,594.6 11,977.2 16,324.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -40.6 908.9 365.5 67.4 1,251.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -5 -122 -114 -84 -125  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -5 -122 -114 -84 -125  
EBIT / employee  -5 -122 -114 -84 -125  
Net earnings / employee  3,520 3,478 1,557 4,739 4,710